Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inducible Degradation of Oncogenic Nucleolin Using an Aptamer-Based PROTAC
Miao Chen, Ping Zhou, Yun Kong, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 2, pp. 1339-1348
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

New-generation advanced PROTACs as potential therapeutic agents in cancer therapy
Chao Wang, Yujing Zhang, Wujun Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Expanding the horizons of targeted protein degradation: A non-small molecule perspective
Xiaowei Huang, Fengbo Wu, Jing Ye, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2402-2427
Open Access | Times Cited: 14
Modified nucleic acid aptamers: development, characterization, and biological applications
Danyang Ji, Hengxin Feng, Shiau Wei Liew, et al.
Trends in biotechnology (2023) Vol. 41, Iss. 11, pp. 1360-1384
Closed Access | Times Cited: 29
PROTACs: A novel strategy for cancer drug discovery and development
Xin Han, Yi Sun
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 23
Leveraging aptamers for targeted protein degradation
Zhihao Yang, Qiuxiang Pang, Jun Zhou, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 11, pp. 776-785
Closed Access | Times Cited: 20
Restraining the power of Proteolysis Targeting Chimeras in the cage: A necessary and important refinement for therapeutic safety
Renshuai Zhang, Songbo Xie, Jie Ran, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 5
Closed Access | Times Cited: 9
An engineered DNA aptamer-based PROTAC for precise therapy of p53-R175H hotspot mutant-driven cancer
Lingping Kong, Fanlu Meng, Ping Zhou, et al.
Science Bulletin (2024) Vol. 69, Iss. 13, pp. 2122-2135
Open Access | Times Cited: 8
PROTAC-biomacromolecule conjugates for precise protein degradation in cancer therapy: A review
Chao Wang, Yujing Zhang, Wanpeng Yu, et al.
International Journal of Biological Macromolecules (2024) Vol. 261, pp. 129864-129864
Closed Access | Times Cited: 6
Repurposing AS1411 for constructing ANM-PROTACs
Xuekun Fu, Jin Li, Xinxin Chen, et al.
Cell chemical biology (2024) Vol. 31, Iss. 7, pp. 1290-1304.e7
Closed Access | Times Cited: 6
Targeted Degradation of HCV Polymerase by GalNAc-Conjugated ApTACs for Pan-Genotypic Antiviral Therapy with High Resistance Barriers
Wei Pan, Sijin Wu, Honglin Zhou, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
PROTACs coupled with oligonucleotides to tackle the undruggable
Guangshuai Zhang, Si Yan, Yan Liu, et al.
Bioanalysis (2025), pp. 1-16
Closed Access
Selective degradation of the p53‐R175H oncogenic hotspot mutant by an RNA aptamer‐based PROTAC
Lingping Kong, Fanlu Meng, Sijin Wu, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 18
Targeted protein degradation in drug development: Recent advances and future challenges
Jian H. Song, Mingzheng Hu, Jun Zhou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115839-115839
Closed Access | Times Cited: 14
Antitumor Effect of Anti‐c‐Myc Aptamer‐Based PROTAC for Degradation of the c‐Myc Protein
Yuchun Wang, Gang Yang, Xinyu Zhang, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Closed Access | Times Cited: 5
PROTAC: Novel degradable approach for different targets to treat breast cancer
Zhenjie Wang, Siyao Che, Zhiqiang Yu
European Journal of Pharmaceutical Sciences (2024) Vol. 198, pp. 106793-106793
Open Access | Times Cited: 5
Targeted degradation of membrane and extracellular proteins with LYTACs
Yuyang Li, Yang Yang, Renshuai Zhang, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 4
Engineering artificial non-coding RNAs for targeted protein degradation
Congcong Cao, Aolin Li, Chaojie Xu, et al.
Nature Chemical Biology (2024)
Closed Access | Times Cited: 3
Bioorthogonal Aptamer‐ATTEC Conjugates for Degradation of Alpha‐Synuclein via Autophagy‐Lysosomal Pathway
Xiaofeng Liao, Geng Qin, Zhenqi Liu, et al.
Small (2023) Vol. 20, Iss. 8
Open Access | Times Cited: 10
Development of DNA Aptamer-Based PROTACs That Degrade the Estrogen Receptor
Haruna Tsujimura, Miyako Naganuma, Nobumichi Ohoka, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 6, pp. 827-832
Open Access | Times Cited: 9
Targeted degradation of VEGF with bispecific aptamer-based LYTACs ameliorates pathological retinal angiogenesis
Ping Zhou, Sai Zhang, Li Lin, et al.
Theranostics (2024) Vol. 14, Iss. 13, pp. 4983-5000
Open Access | Times Cited: 2
Emerging Strategies in Proteolysis-Targeting Chimeras (PROTACs): Highlights from 2022
T. N. Rekha, Dongyun Shin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5190-5190
Open Access | Times Cited: 7
Current Status of Oligonucleotide-Based Protein Degraders
Po‐Chang Shih, Miyako Naganuma, Yosuke Demizu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 765-765
Open Access | Times Cited: 6
Targeted protein degradation might present a novel therapeutic approach in the fight against African trypanosomiasis
Ammar Usman Danazumi, Ibtida Tabassum Ishmam, Salisu Idris, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 186, pp. 106451-106451
Open Access | Times Cited: 6
A Modified Tridecapeptide Probe for Imaging Cell Junction
Jingrui Li, Yuhan Wu, Chunyu Liu, et al.
(2024)
Open Access | Times Cited: 1
A Photoactivatable Upconverting Nanodevice Boosts Lysosomal Escape of PROTAC Degraders for Enhanced Combination Therapy
Jiayin Zhan, Xiang Li, Yueru Mu, et al.
Biomaterials Science (2024) Vol. 12, Iss. 14, pp. 3686-3699
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top